DE3264415D1 - The crystalline anhydrous form of (3s-(3 alpha(z),4 beta))-3-(((2-amino-4-thiazolyl)(1-carboxy-1-methylethoxy)-imino)-acetyl)-amino)-4-methyl-2-oxo-1-azetidinesulfonic acid, method for its preparation, mixture and pharmaceutical composition containing it - Google Patents

The crystalline anhydrous form of (3s-(3 alpha(z),4 beta))-3-(((2-amino-4-thiazolyl)(1-carboxy-1-methylethoxy)-imino)-acetyl)-amino)-4-methyl-2-oxo-1-azetidinesulfonic acid, method for its preparation, mixture and pharmaceutical composition containing it

Info

Publication number
DE3264415D1
DE3264415D1 DE8282106227T DE3264415T DE3264415D1 DE 3264415 D1 DE3264415 D1 DE 3264415D1 DE 8282106227 T DE8282106227 T DE 8282106227T DE 3264415 T DE3264415 T DE 3264415T DE 3264415 D1 DE3264415 D1 DE 3264415D1
Authority
DE
Germany
Prior art keywords
amino
methylethoxy
imino
thiazolyl
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282106227T
Other languages
English (en)
Inventor
David M Floyd
Octavian R Kocy
Donald C Monkhouse
James D Pipkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of DE3264415D1 publication Critical patent/DE3264415D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE8282106227T 1981-07-13 1982-07-12 The crystalline anhydrous form of (3s-(3 alpha(z),4 beta))-3-(((2-amino-4-thiazolyl)(1-carboxy-1-methylethoxy)-imino)-acetyl)-amino)-4-methyl-2-oxo-1-azetidinesulfonic acid, method for its preparation, mixture and pharmaceutical composition containing it Expired DE3264415D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28263681A 1981-07-13 1981-07-13

Publications (1)

Publication Number Publication Date
DE3264415D1 true DE3264415D1 (en) 1985-08-01

Family

ID=23082417

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282106227T Expired DE3264415D1 (en) 1981-07-13 1982-07-12 The crystalline anhydrous form of (3s-(3 alpha(z),4 beta))-3-(((2-amino-4-thiazolyl)(1-carboxy-1-methylethoxy)-imino)-acetyl)-amino)-4-methyl-2-oxo-1-azetidinesulfonic acid, method for its preparation, mixture and pharmaceutical composition containing it

Country Status (11)

Country Link
EP (1) EP0070024B1 (de)
JP (1) JPS5823689A (de)
AT (1) ATE14016T1 (de)
AU (1) AU557096B2 (de)
CA (1) CA1181075A (de)
DE (1) DE3264415D1 (de)
IE (1) IE53109B1 (de)
IL (1) IL66286A (de)
NZ (1) NZ201000A (de)
PH (1) PH19140A (de)
ZA (1) ZA824418B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
EP0117053A1 (de) * 1983-02-10 1984-08-29 Ajinomoto Co., Inc. Azetidinonderivate
US4826973A (en) * 1984-07-20 1989-05-02 E. R. Squibb & Sons, Inc. Delta form of aztreonam and preparation thereof
US4638062A (en) * 1985-06-17 1987-01-20 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinesulfonic acids
CA1339136C (en) * 1987-07-01 1997-07-29 Sailesh Amilal Varia Amorphous form of aztreonam
US7214364B2 (en) 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
PT1353647E (pt) 2000-12-27 2011-05-24 Gilead Sciences Inc Aztreonam inal?vel para tratamento e preven??o de infec??es bacterianas pulmonares
CN1545514A (zh) * 2001-08-27 2004-11-10 阿拉宾度药业有限公司 β型晶体无水氨曲南的生产方法
KR100687001B1 (ko) 2002-08-05 2007-02-27 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 아즈트레오남의 제법
AU2002356646A1 (en) * 2002-12-11 2004-06-30 Pari Gmbh Pharmaceutical compositions for the pulmonary delivery of aztreonam
WO2004103999A1 (en) * 2003-05-15 2004-12-02 TEVA Gyógyszergyár Részvénytársaság AZTREONAM β POLYMORPH WITH VERY LOW RESIDUAL SOLVENT CONTENT
US7262293B2 (en) 2003-07-02 2007-08-28 Corus Pharma Aztreonam L-lysine and methods for the preparation thereof
MX2007000526A (es) 2005-05-09 2007-03-28 Sicor Inc Proceso para elaborar aztreonam.
CN102311431B (zh) * 2011-08-30 2014-12-10 海南海药股份有限公司 一种制备无水β-氨曲南的方法
CN111018746A (zh) * 2019-12-16 2020-04-17 山东金城柯瑞化学有限公司 一种氨曲南主环合成中间体n-苄氧羰基-l-苏氨酸酰胺的合成方法
CN112645943A (zh) * 2020-12-25 2021-04-13 南京华盖制药有限公司 一种含氨曲南无定型系统的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196202A (en) * 1980-02-07 1984-07-31 Squibb & Sons Inc Beta-lactam antibiotics (of azetidine-sulphonic acid type)

Also Published As

Publication number Publication date
ZA824418B (en) 1983-04-27
ATE14016T1 (de) 1985-07-15
IL66286A (en) 1986-03-31
PH19140A (en) 1986-01-10
IE821440L (en) 1983-01-13
IE53109B1 (en) 1988-06-22
NZ201000A (en) 1985-08-16
EP0070024B1 (de) 1985-06-26
CA1181075A (en) 1985-01-15
AU8501082A (en) 1983-01-20
IL66286A0 (en) 1982-11-30
EP0070024A1 (de) 1983-01-19
AU557096B2 (en) 1986-12-04
JPH0343273B2 (de) 1991-07-01
JPS5823689A (ja) 1983-02-12

Similar Documents

Publication Publication Date Title
DE3264415D1 (en) The crystalline anhydrous form of (3s-(3 alpha(z),4 beta))-3-(((2-amino-4-thiazolyl)(1-carboxy-1-methylethoxy)-imino)-acetyl)-amino)-4-methyl-2-oxo-1-azetidinesulfonic acid, method for its preparation, mixture and pharmaceutical composition containing it
GR3029873T3 (en) Amorphous form of aztreonam
PH24503A (en) New pharmaceutical compositions having psychotropic activity
US4476308B1 (de)
PT84041A (en) Process for the preparation of optically pure s-(-)-1-propyl-2:,6:-pipecoloxylidide hydrochloride monohydrate and of pharmaceutical compositions containing the same
PT85375A (en) Process for the preparation of beta-lactam compounds of intermediates for their synthesis and of pharmaceutical compositions containing the same
PH25741A (en) Heterocyclic compounds, pharmaceutical composition containing said compound, method of use thereof
CS649787A2 (en) Method of new 4,5-dihydrooxazole derivatives production
DE3276580D1 (en) 2-phenylimidazo(2,1-b)benzothiazole compounds, salts thereof, process for producing them, and pharmaceutical compositions containing them
NZ212658A (en) Phenylnaphthyridine derivatives and pharmaceutical compositions
EG19008A (en) A method for the preparation of novel iodinated nonionic triodobenzene compounds and of contrast media containing them
ES2003198A6 (es) Un procedimiento para la preparacion de esteroides aminoglicosidicos.
IL84521A0 (en) Salts of(3s(z))-2-(((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl)-amino)-2-oxoethylidene)-amino)oxy)acetic acid,process for the preparation thereof and pharmaceutical compositions containing the same
NO170014C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse (3s(z))-2-(((1-(2-amino-4-tiazolyl)-2-((2,2-dimetyl-4-okso-1-(sulfooksy)-3-azetidinyl)amino)-2-oksoetyliden)amino)oksy)-eddiksyre
AU3527484A (en) N-benzyl-n-phenyl-b-pyrrolidinyl-f-isobutoxy-propylamine
ZA885520B (en) Beta-lactam compound,process for preparing the same intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same
AU556962B2 (en) Pyridobenzodiazepinone derivatives
PT70779A (en) Process for preparing novel crystalline forms of n-2-(6-methoxy)benzothiazolyl n' -phenyl urea
JPS57145845A (en) Novel peptide and its preparation
EP0128437A3 (en) Nortropine derivative, process for its preparation and its use
GR3001003T3 (en) Novel pregnane derivatives, processes for their preparaton and pharmaceutical compositions containing same
GR3002538T3 (en) Crystal modification of 3-methoxy-4-(4'-amino benzolsulfonamido)-1,2,5-thiadiazole, process for its production and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
8364 No opposition during term of opposition